Showing results (1501-1510 of 1,558) with videos related to

Sort By:
Pageof 156
JCO Oncology Practice|September 25, 2023
Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022Jenny S Guadamuz, Xiaoliang Wang, Trevor J Royce, et al.
JCO Oncology Practice|September 22, 2023
Health Care Contact Days Experienced by Decedents With Advanced GI CancerVishal R Patel, Vidhyalakshmi Ramesh, Alexander K Tsai, et al.
JCO Oncology Practice|September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled TrialHuma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
JCO Oncology Practice|September 20, 2023
Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain MetastasesRuchira Mahashabde, Sajjad A Bhatti, Bradley C Martin, et al.
JCO Oncology Practice|September 21, 2023
Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 PandemicDeborah B Ejem, Stephen Wechsler, Sarah Gallups, et al.
JCO Oncology Practice|June 19, 2023
Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021Joshua C Pritchett, Bijan J Borah, Ruchita Dholakia, et al.
JCO Oncology Practice|February 18, 2026
Associations Between Nutritional Status, Sleep Quality, and Clinical Factors in Patients With Metastatic Prostate CancerDigdem Dogan Akagunduz, Hilal Sahin, Engin Hendem, et al.
JCO Oncology Practice|February 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing TestingMadelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh, et al.
JCO Oncology Practice|February 25, 2026
Cost-Effectiveness of Dabrafenib Plus Trametinib Versus Standard Chemotherapy in BRAFV600E-Mutant Pediatric Low-Grade GliomaBryan Gascon, Cindy Gauvreau, Alan Yang, et al.
JCO Oncology Practice|March 17, 2026
Economic Evaluation of GARDE: A Digital Health Platform for Population-Level Hereditary Cancer Risk AssessmentMuhammad Danyal Ahsan, Kimberly A Kaphingst, Wendy K Kohlmann, et al.
Pageof 156